Sep 07, 2017 NEW YORK (GenomeWeb) – The US Senate’s appropriations committee today approved a funding bill that would increase the National Institutes of Health’s fiscal 2018 budget by $2 billion to $36.1 billion. The bill — which was cleared by the Senate Labor, Health and Human Services, and Education Appropriations Subcommittee yesterday — was approved by […]
In order to maximize your funding potential, all sources of funding must be considered, including the less traditional ones. The NIH’s R21 mechanism aims to fund very early stage proof of concept type programs of up to 2 years at about $300,000, whereas the R01 mechanism is more suitable for longer programs of up to […]
FreeMind is a proud supporter of the upcoming Inv€$tival Showcase Where: London, UK When: November 14, 2017 Showcasing innovative investable Biotech, Medtech and Digital Health investment and partnering opportunities. Biotech and Money connects corporates to capital, and the Inv€$tival Showcase is our most direct way of showcasing the latest investable private and public life science opportunities […]
FreeMind is pleased to support The MedTech Conference powered by AdvaMed Where: San Jose, CA When: September 25-27, 2017 The MedTech Conference powered by AdvaMed is the leading gathering in North America of global medtech executives with regulatory, reimbursement, business development, legal, IP, marketing, quality, compliance, HR and other key responsibilities. Along with industry leaders, the […]
SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics. SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, […]
We all had an amazing week in San Diego, seeing hundreds of new and familiar faces! FreeMind was quite pleased to give away 5 bottles of Grants Whisky this year and we look forward to helping our clients win hundreds of thousands of dollars in governments grants before the year is out. Two lucky winners: Mary […]
Every year, US-based non-dilutive sources of funding award billions of dollars towards clinical stage research in the Life Sciences. Funding is available for clinical stage funding across scientific fields including Infectious Diseases, Neurosciences, Cardiovascular, and many more. These funds come from multiple Institutes within the NIH, such as NIAID, NIAMS, NIDDK, from BARDA, and from […]
Every year, US-based non-dilutive sources of funding award billions of dollars towards pre-clinical stage research in the Life Sciences. Funding is available for pre-clinical research across scientific fields including Infectious Diseases, Oncology, Neurosciences, and many more. These funds come from Institutes within the NIH, such as NIAID, NCI, NINDS, the NSF, the DoD, and private […]